InDevR taps medtech vet Bitz for commercial chief
Life science and medical device analytical tech company InDevR said late last month it tapped medtech vet Dawn Bitz as its new chief commercial officer, effective immediately.
“Dawn is a tremendous leader who will build a world-class commercial team at InDevR. Her experience in growing world-class businesses, planning and executing commercial strategies and overseeing multiple launches will play a critical role in InDevR’s next phase of growth,” CEO Dr. Kathy Rowlen said in a press release.
“I am excited to join InDevR at a time when we have the opportunity to shape commercial strategies for new and innovative ways to streamline and expedite the commercial vaccine production process. I look forward to building and leading a top-tier organization that will impact our ability to fight influenza and other public health issues,” Bitz said in prepared remarks.